Global Antimicrobial Resistance Surveillance Market Insights Forecasts to 2032

• The Global Antimicrobial Resistance Surveillance Market Size was valued at USD 5.61 Billion in 2022.
• The Market Size is Growing at a CAGR of 5.8% from 2022 to 2032
• The Worldwide Antimicrobial Resistance Surveillance Market Size is expected to reach USD 9.92 Billion by 2032
• Asia Pacific is expected to Grow the fastest during the forecast period

The Global Antimicrobial Resistance Surveillance Market Size is anticipated to exceed USD 9.92 Billion by 2032, Growing at a CAGR of 5.8% from 2022 to 2032. Continued innovation in diagnostics, data integration, and international collaboration are expected to drive advancements in this critical sector, ultimately safeguarding the efficacy of antibiotics and preserving global public health.          

Market Overview

The global antimicrobial resistance surveillance market is critical to addressing one of today's most pressing public health issues: the rise of antimicrobial resistance (AMR). AMR occurs when microorganisms, such as bacteria and viruses, develop resistance to the medications designed to treat them, rendering these medications less effective or ineffective. This burgeoning market is driven by the urgent need for robust surveillance systems that can monitor and track the spread of AMR, helping healthcare professionals make informed decisions about antibiotic prescriptions and treatment strategies. The consequences of inadequate surveillance are dire, as AMR can lead to increased mortality rates, longer hospital stays, and higher healthcare costs. Key components of the global antimicrobial resistance surveillance market include advanced laboratory techniques, data analytics, and information sharing platforms that enable the collection and analysis of data from healthcare facilities, laboratories, and clinics worldwide. This data-driven approach empowers healthcare stakeholders to detect emerging resistance patterns, devise targeted interventions, and develop new antimicrobial therapies.

Report Coverage

This research report categorizes the market for the global antimicrobial resistance surveillance market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the antimicrobial resistance surveillance market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the antimicrobial resistance surveillance market.

Driving Factors

The primary driver is the alarming increase in antimicrobial resistance across the globe. As pathogens become resistant to existing antibiotics, there is an urgent need to monitor resistance patterns to guide effective treatment and public health responses. Increased awareness among healthcare professionals, policymakers, and the public about the dire consequences of AMR has led to greater emphasis on surveillance efforts. This heightened awareness drives investment in surveillance technologies and systems. The development of advanced diagnostic technologies, such as molecular diagnostics and genomics, enables more accurate and rapid identification of drug-resistant pathogens. These innovations enhance surveillance capabilities. Pharmaceutical companies have a vested interest in monitoring AMR as it affects the efficacy of their antibiotic products. They may invest in surveillance initiatives and research to protect their investments.

Restraining Factors

The absence of standardized methods and guidelines for AMR surveillance can hinder data comparability and interoperability across regions and countries. This lack of standardization makes it challenging to create a cohesive global surveillance network. Many countries, particularly low- and middle-income nations, face resource constraints that limit their ability to invest in sophisticated surveillance infrastructure, laboratory facilities, and skilled personnel.

Market Segmentation

The Global Antimicrobial Resistance Surveillance Market share is classified into solution and application.

• The kits segment accounted for a significant share of the global antimicrobial resistance surveillance market in 2022.        

The global antimicrobial resistance surveillance market is categorized by solution into kits, system, surveillance software, and service. Among these, the kits segment accounted for a significant share of the global antimicrobial resistance surveillance market in 2022. AMR surveillance kits consist of diagnostic reagents and consumables used in laboratories for detecting and identifying antimicrobial-resistant pathogens. These kits are essential for conducting microbiological tests to determine the resistance profiles of infectious agents. They typically include culture media, antibiotic susceptibility testing (AST) panels, and molecular testing reagents. The kits segment is crucial in providing the necessary tools for frontline healthcare workers and researchers to assess AMR patterns efficiently.       

• The clinical diagnostics segment is expected to hold the largest share of the global antimicrobial resistance surveillance market during the forecast period. 

Based on the application, the global antimicrobial resistance surveillance market is divided into clinical diagnostics, public health surveillance. Among these, the clinical diagnostics segment is expected to hold the largest share of the global antimicrobial resistance surveillance market during the forecast period. Clinical diagnostics focus on identifying antimicrobial resistance in individual patients, primarily within healthcare settings like hospitals and clinics. The goal is to guide healthcare providers in selecting the most effective antibiotic treatments for patients with infections. This segment includes diagnostic tests and tools used directly in patient care. These may involve culture and sensitivity testing, molecular diagnostics (PCR), and rapid diagnostic tests (RDTs) to determine the resistance profile of pathogens.

Regional Segment Analysis of the Global Antimicrobial Resistance Surveillance Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the global antimicrobial resistance surveillance market over the predicted timeframe.

North America is projected to hold the largest share of the global antimicrobial resistance surveillance market over the predicted years. North America, including the United States and Canada, has well-established healthcare systems and advanced laboratory facilities. These countries invest significantly in AMR surveillance, with a focus on clinical diagnostics and data collection. Clinical diagnostics, particularly in hospital settings, have held a significant share in North America due to the region's robust healthcare infrastructure and high standards for patient care. The CDC (Centers for Disease Control and Prevention) in the United States leads AMR surveillance efforts. Various state health departments and public health agencies collaborate to track AMR trends, with a strong emphasis on healthcare-associated infections.  

Asia Pacific is expected to grow at the fastest pace in the global antimicrobial resistance surveillance market during the forecast period. China has invested significantly in AMR surveillance, with a national network for data collection. The Asia-Pacific region also collaborates with international organizations, such as the World Health Organization (WHO). The Asia-Pacific region, including countries like China and India, faces unique challenges due to its diverse healthcare systems and population sizes. Public health surveillance is gaining prominence in the Asia-Pacific region, driven by regional and global health organizations and initiatives.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global antimicrobial resistance surveillance along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Luminex Corporation  
• Thermo Fisher Scientific 
• BioSpace 
• Cepheid  
• Accelerate Diagnostics, Inc.  
• Liofilchem S.r.l.  
• Becton, Dickinson and Company  
• Biomerieux  
• Bruker  
• Danaher  
• Merck KgaA  
• Bio-Rad  
• Qiagen  
• Abbott Laboratories
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2032. Spherical Insights has segmented the Global Antimicrobial Resistance Surveillance Market based on the below-mentioned segments: 

Global Antimicrobial Resistance Surveillance Market, By Solution

• Kits
• System
• Surveillance Software
• Service

Global Antimicrobial Resistance Surveillance Market, By Application

• Clinical Diagnostics
• Public Health Surveillance

Global Antimicrobial Resistance Surveillance Market, By End User

• Hospitals
• Clinics
• Academic
• Research Institutes

Global Antimicrobial Resistance Surveillance Market, By Region

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Uk
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of Middle East & Africa